characteristics.text: SAMN38084017
characteristics.characteristic: External Id
characteristics.text: Chromatin Biochemistry and Epigenetics Laboratory, Institute of Genetics and Cancer, University _of Edinburgh
characteristics.characteristic: INSDC center name
characteristics.text: 2025-05-28T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2025-05-28T19:57:14.413Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS19409330
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS19409330
characteristics.characteristic: SRA accession
characteristics.text: CBX8 (Cell Signalling, 14696S)
characteristics.characteristic: antibody
characteristics.text: SU-DIPGXIII
characteristics.characteristic: cell type
characteristics.text: missing
characteristics.characteristic: collection_date
characteristics.text: missing
characteristics.characteristic: geo_loc_name
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Brain
characteristics.characteristic: source_name
characteristics.text: Brain
characteristics.characteristic: tissue
characteristics.text: TAZ-CBX8-Rep1
characteristics.characteristic: title
characteristics.text: H3K27M-positive SU-DIPGXIII cells treated with 2µM Tazemetostat for 6 days
characteristics.characteristic: treatment